treatment of primary immune thrombocytopenia
All entries for: Eli Lilly and Company
August 22, 2026
Eli Lilly and Company
Orphan Drug Designation
Indianapolis
1-50 employees
Disease Area: Rare Diseases
treatment of primary immune thrombocytopenia